AU2003276957A1 - Quaternised ammonium cyclodextrin compounds - Google Patents

Quaternised ammonium cyclodextrin compounds

Info

Publication number
AU2003276957A1
AU2003276957A1 AU2003276957A AU2003276957A AU2003276957A1 AU 2003276957 A1 AU2003276957 A1 AU 2003276957A1 AU 2003276957 A AU2003276957 A AU 2003276957A AU 2003276957 A AU2003276957 A AU 2003276957A AU 2003276957 A1 AU2003276957 A1 AU 2003276957A1
Authority
AU
Australia
Prior art keywords
compound
alkylene
group selected
cyclodextrin
cyclodextrin compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276957A
Other languages
English (en)
Inventor
Georg Ludwig Kis
Christian Schoch
Jozsef Szejtli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003276957A1 publication Critical patent/AU2003276957A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2003276957A 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds Abandoned AU2003276957A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP02013074 2002-06-13
EP02013074.6 2002-06-13
EP02028554.0 2002-12-20
EP02028554 2002-12-20
PCT/EP2003/006192 WO2003105867A1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds

Publications (1)

Publication Number Publication Date
AU2003276957A1 true AU2003276957A1 (en) 2003-12-31

Family

ID=29737927

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276957A Abandoned AU2003276957A1 (en) 2002-06-13 2003-06-12 Quaternised ammonium cyclodextrin compounds

Country Status (15)

Country Link
US (4) US20050222085A1 (https=)
EP (1) EP1515729B1 (https=)
JP (2) JP4773721B2 (https=)
CN (1) CN100589809C (https=)
AT (1) ATE386532T1 (https=)
AU (1) AU2003276957A1 (https=)
BR (1) BR0311722A (https=)
CA (1) CA2487332C (https=)
CY (1) CY1108099T1 (https=)
DE (1) DE60319221T2 (https=)
DK (1) DK1515729T3 (https=)
ES (1) ES2301807T3 (https=)
PT (1) PT1515729E (https=)
SI (1) SI1515729T1 (https=)
WO (1) WO2003105867A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
US8580954B2 (en) 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
CN101757621B (zh) * 2008-11-28 2012-07-04 天津金耀集团有限公司 一种眼部抗炎的环糊精包合药物组合物
US9642920B2 (en) * 2009-06-03 2017-05-09 Case Western Reserve University Therapeutic agent delivery system and method
CN102276761A (zh) * 2010-06-11 2011-12-14 南京理工大学 单取代铵基正电型-β-环糊精及其制备方法
GB201114459D0 (en) * 2011-08-22 2011-10-05 Isis Innovation Anti-bacterial compounds
CN103497275B (zh) * 2013-08-09 2015-12-23 华北电力大学(保定) 一种抗菌、抗病毒胍盐星形聚合物及其制备方法和应用
CZ307458B6 (cs) * 2014-11-25 2018-09-12 Spur A.S. Vícevrstvý kryt rány s aktivní vrstvou a způsob jeho výroby
US20170360040A1 (en) * 2014-12-02 2017-12-21 B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University Modified polysaccharides for use as anti-microbial agents
CN109487588B (zh) * 2018-11-19 2021-04-20 绍兴永通印花有限公司 一种印花用涤纶织物处理液及其使用方法
CA3128516C (en) 2019-02-14 2024-03-12 Cyclopure, Inc. Charge-bearing cyclodextrin polymeric materials and methods of making and using same
CN109836512A (zh) * 2019-03-04 2019-06-04 西南石油大学 一种新型β-CD双子表面活性剂为稠化剂的清洁压裂液
CN112386710A (zh) * 2020-12-09 2021-02-23 星拜(苏州)生物科技有限公司 一种利用包埋技术改善紫檀芪水溶性的方法
CN116987213B (zh) * 2022-04-26 2025-09-09 中国石油化工股份有限公司 一种具有表面活性剂功能的化合物、一种表面活性剂及其制备方法
WO2024151850A1 (en) 2023-01-12 2024-07-18 Cyclopure, Inc. Regeneration of polymeric cyclodextrin adsorbents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453257A (en) * 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
JPS58210901A (ja) * 1982-06-01 1983-12-08 Kao Corp シクロデキストリン誘導体およびその製造方法
IT1229133B (it) * 1989-03-09 1991-07-22 Farmhispania Sali ammonici di policiclodestrine per l'impiego come agenti ipocolesterolemizzanti
JPH0481401A (ja) * 1990-07-24 1992-03-16 Toppan Printing Co Ltd シクロデキストリン誘導体
DE69127256T2 (de) * 1990-05-21 1998-02-12 Toppan Printing Co Ltd Cyclodextrinderivat
JPH0665307A (ja) * 1992-06-17 1994-03-08 Sankyo Co Ltd シクロデキストリン誘導体
WO1996011003A1 (en) * 1994-10-10 1996-04-18 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
CA2320772A1 (en) * 1998-02-23 1999-08-26 Cyclops, Ehf. High-energy cyclodextrin complexes

Also Published As

Publication number Publication date
EP1515729B1 (en) 2008-02-20
CY1108099T1 (el) 2014-02-12
EP1515729A1 (en) 2005-03-23
US20120004158A1 (en) 2012-01-05
JP4773721B2 (ja) 2011-09-14
DE60319221T2 (de) 2009-03-05
CA2487332C (en) 2012-05-15
US20050222085A1 (en) 2005-10-06
DE60319221D1 (de) 2008-04-03
DK1515729T3 (da) 2008-06-16
US20130137657A1 (en) 2013-05-30
CA2487332A1 (en) 2003-12-24
WO2003105867A1 (en) 2003-12-24
SI1515729T1 (sl) 2008-08-31
CN1658888A (zh) 2005-08-24
CN100589809C (zh) 2010-02-17
PT1515729E (pt) 2008-05-30
BR0311722A (pt) 2005-03-01
JP2011006448A (ja) 2011-01-13
ATE386532T1 (de) 2008-03-15
US20090110734A1 (en) 2009-04-30
ES2301807T3 (es) 2008-07-01
JP2005529175A (ja) 2005-09-29

Similar Documents

Publication Publication Date Title
AU2003276957A1 (en) Quaternised ammonium cyclodextrin compounds
Jeon et al. Effect of antimicrobial activity by chitosan oligosaccharide N-conjugated with asparagine
WO2004014384A3 (en) Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
WO2002094889A3 (de) Nieder- und hochmolekulare emulgatoren, insbesondere auf basis von polyisobutylen, sowie deren mischungen
HRP20060277B1 (hr) 6-0-supstituirani ketolidi antibakterijskog djelovanja
CA2354774A1 (en) Farnesyl protein transferase inhibitors
ATE496997T1 (de) Verfahren zur stabilisierung und/oder isolierung von nukleinsäuren
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
RU2450015C2 (ru) Производные аминотиазола и их применение в качестве антибактериальных средств
BR0315302A (pt) Benzoxazinonas substituìdas e seus usos
DE602005009924D1 (en) Synthetische multiple quaternäre ammoniumsalze
AU2003210203A1 (en) Aqueous dispersions consisting of polycarbodiimides
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
HUP9902465A1 (hu) Új amidínium-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2004062562A3 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
EP4242249A8 (en) Surface treatment agent
EP1027880A3 (de) Verwendung von quaternären Ammoniumverbindungen als Antitranspirantien
AR012883A1 (es) Compuestos derivados de ciclobutilamina sustituida, composicion farmaceutica y agente antibacteriano.
HUP0204217A2 (en) Novel a-500359 derivatives
AU3300797A (en) Selenophene anti-tumor agents
DE602005018100D1 (de) Zu lipidmembranen in archeabakterien analoge verbindungen und liposomale zusammensetzungen mit diesen verbindungen
AU6734798A (en) New derivatives of erythromycin, their preparation process and their use as medicaments
RU94022756A (ru) Агент, ускоряющий разрастание эндотелиальных клеток
PRUESS et al. ANTIMETABOLITES PRODUCED BY MICROORGANISMS. XI. 1) 1-(S)-HYDROXY-2-(S, S)-VALYLAMIDO-CYCLOBUTANE-1-ACETIC ACID
TW200724145A (en) Substituted acrylamide derivatives and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase